JP2014531436A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531436A5
JP2014531436A5 JP2014529985A JP2014529985A JP2014531436A5 JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5 JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5
Authority
JP
Japan
Prior art keywords
atoms
cancer
hal
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014529985A
Other languages
English (en)
Japanese (ja)
Other versions
JP5964974B2 (ja
JP2014531436A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054900 external-priority patent/WO2013040059A1/en
Publication of JP2014531436A publication Critical patent/JP2014531436A/ja
Publication of JP2014531436A5 publication Critical patent/JP2014531436A5/ja
Application granted granted Critical
Publication of JP5964974B2 publication Critical patent/JP5964974B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014529985A 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン Expired - Fee Related JP5964974B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161533601P 2011-09-12 2011-09-12
US61/533,601 2011-09-12
PCT/US2012/054900 WO2013040059A1 (en) 2011-09-12 2012-09-12 Novel imidazole amines as modulators of kinase activity

Publications (3)

Publication Number Publication Date
JP2014531436A JP2014531436A (ja) 2014-11-27
JP2014531436A5 true JP2014531436A5 (https=) 2016-06-09
JP5964974B2 JP5964974B2 (ja) 2016-08-03

Family

ID=46881179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014529985A Expired - Fee Related JP5964974B2 (ja) 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン

Country Status (24)

Country Link
US (2) US9145392B2 (https=)
EP (1) EP2755965B1 (https=)
JP (1) JP5964974B2 (https=)
KR (1) KR101995605B1 (https=)
CN (1) CN104080782B (https=)
AU (1) AU2012308696B2 (https=)
BR (1) BR112014005554A2 (https=)
CA (1) CA2844830C (https=)
DK (1) DK2755965T3 (https=)
EA (1) EA025098B1 (https=)
ES (1) ES2644536T3 (https=)
HR (1) HRP20171554T1 (https=)
HU (1) HUE035019T2 (https=)
IL (1) IL231383A (https=)
LT (1) LT2755965T (https=)
MX (1) MX346095B (https=)
NO (1) NO2791461T3 (https=)
PL (1) PL2755965T3 (https=)
PT (1) PT2755965T (https=)
RS (1) RS56534B1 (https=)
SG (2) SG10201606301YA (https=)
SI (1) SI2755965T1 (https=)
WO (1) WO2013040059A1 (https=)
ZA (1) ZA201401013B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103930407B (zh) * 2011-09-12 2019-02-26 默克专利有限公司 用作激酶活性调节剂的氨基嘧啶衍生物
AU2013333938A1 (en) 2012-10-16 2015-04-09 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
AR093511A1 (es) 2012-11-16 2015-06-10 Merck Patent Gmbh Derivados de imidazol-piperidinilo como moduladores de la actividad de cinasas
SG11201505999VA (en) * 2013-03-11 2015-08-28 Merck Patent Gmbh 6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity
US9434714B2 (en) 2014-02-11 2016-09-06 Merck Patent Gmbh Pyrimidine imidazole amines as modulators of kinase activity
EP3205645B1 (en) 2014-04-18 2019-10-23 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
KR20200093159A (ko) 2019-01-28 2020-08-05 주식회사 링크모션 스마트 팜 모듈 구조물
CA3164134A1 (en) 2019-12-06 2021-06-10 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11866421B2 (en) 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
CN117567435A (zh) * 2022-01-30 2024-02-20 上海市第十人民医院 谷氨酰胺环化酶抑制剂及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
WO2004092154A1 (en) 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
AU2004278413B2 (en) 2003-09-30 2008-07-31 Irm Llc Compounds and compositions as protein kinase inhibitors
JP4800216B2 (ja) 2003-10-24 2011-10-26 エグゼリクシス, インコーポレイテッド p70S6キナーゼモジュレーターおよび使用方法
DE602004014969D1 (de) 2003-11-21 2008-08-21 Novartis Ag 1h-imidazochinolinderivate als proteinkinaseinhibitoren
CN1889958A (zh) 2003-12-09 2007-01-03 美国政府健康及人类服务部 抑制免疫应答或治疗增生性疾病的方法
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
CA2590961C (en) 2004-12-28 2013-11-26 Exelixis, Inc. [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
JP2008528506A (ja) * 2005-01-19 2008-07-31 ニューロジェン・コーポレーション ヘテロアリール置換ピペラジニル−ピリジン類縁体
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
EP1902032A1 (en) 2005-06-22 2008-03-26 Astex Therapeutics Limited Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
UA99284C2 (ru) * 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es) * 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
NZ595087A (en) 2009-02-11 2013-03-28 Merck Patent Gmbh Novel amino azaheterocyclic carboxamides
US9586938B2 (en) 2010-07-29 2017-03-07 Merck Patent Gmbh Cyclic amine azaheterocyclic carboxamides
UA110113C2 (xx) 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
PT2643313T (pt) 2010-11-24 2016-10-11 Merck Patent Gmbh Quinazolina carboxamida azetidinas

Similar Documents

Publication Publication Date Title
JP2014531436A5 (https=)
JP2014527082A5 (https=)
JP2019533694A5 (https=)
JP6078639B2 (ja) Abl1、abl2およびbcr−abl1の活性を阻害するためのベンズアミド誘導体
IL295799A (en) Trophomyosin receptor kinase (trk) degradation compounds and methods of use
HRP20171554T1 (hr) Novi imidazol amini kao modulatori aktivnosti kinaze
JP2017510555A5 (https=)
JP2017510554A5 (https=)
JP2015526519A5 (https=)
JP2008528467A5 (https=)
JP2016525076A5 (https=)
WO2013115280A1 (ja) ピリドン誘導体
JP2016513660A5 (https=)
JP2016527238A5 (https=)
JP2009542608A5 (https=)
JP2016053042A5 (https=)
HRP20192167T1 (hr) Ciklopropilamini kao lsd1 inhibitori
JP2018515492A5 (https=)
RU2014125230A (ru) Пиридонамиды и их аналоги, демонстрирующие противораковую и антипролиферативную активность
RU2011153788A (ru) Гетероциклические противовирусные соединения
AU2024220775A1 (en) Azolylpyridine pyridazinone amide as sos1 inhibitor
HRP20171655T1 (hr) Derivati aminopirimidina za upotrebu kao modulatori aktivnosti kinaze
JP2019505594A5 (https=)
JP2015529194A5 (https=)
RU2018102087A (ru) Производное 1,4-дизамещенного имидазола